Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
P002 RAB3GAP1, RAB3GAP2 and RAB18: disease genes in Micro and Martsolf syndromes Mark T Handley2, Sarah M Carpanini2, Shin-ichiro Yoshimura3, Stephen Brown1, Danai Bem4, Deborah Morris-Rosendahl5, Francis A Barr6 and Irene Aligianis2 1 University of Edinburgh, Edinburgh, United Kingdom 2 MRC Human Genetics Unit, Edinburgh, United Kingdom 3 University of Liverpool, Liverpool, United Kingdom 4 University of Birmingham, Birmingham, United Kingdom 5 Institut für Humangenetik, Freiburg, Germany 6 University of Oxford, Oxford, United Kingdom Micro and Martsolf syndromes (MIM 60018 and MIM 21270 respectively) are heterogeneous autosomal recessive disorders. Affected children present with abnormalities of the eye (congenital cataracts, micropthalmia, optic atrophy and cortical blindness), brain (microcephaly, developmental delay and polymicrogyria), genitals (hypothalamic hypogonadism) and peripheral nervous system (progressive spastic paraplegia). Disease-causing mutations in RAB3GAP1, RAB3GAP2 and most recently RAB18 have been reported in cases of Micro syndrome, while mutations in RAB3GAP2 have been reported in cases of Martsolf syndrome. We investigated a cohort of 116 families by sequencing these genes and identified pathogenic mutations in ~50% of cases. Among these, we report the first missense mutations in RAB3GAP1 and RAB3GAP2, and the first Martsolf syndrome-causing mutations in RAB3GAP1. These data contribute to an emerging paradigm in which Micro and Martsolf syndromes represent a phenotypic continuum related to the nature and severity of the mutations present in the disease gene: loss-offunction mutations result in Micro syndrome while mutations causing partial loss-of-function or incomplete loss of functional protein cause the milder Martsolf syndrome. RAB3GAP1 and RAB3GAP2 encode the catalytic and noncatalytic subunits of RAB3GAP, a novel Rab GTPase-activating protein with specificity towards RAB3 isoforms. RAB3 is involved in modulating the regulated exocytosis of hormones and neurotransmitters while RAB18 is thought to regulate lipolysis and lipogenesis. We are undertaking biochemical studies to determine the functional relationship between these proteins.